Skip to main content
UCB Login
Menu
Search
Search
Main navigation
Home
Search
Search
User account menu
Log in
Primary tabs
Log in
Create new account
Reset your password
Breadcrumb
Home
Log in
Create new account
Email address
The email address is not made public. It will only be used if you need to be contacted about your account or for opted-in notifications.
Password
Confirm password
Provide a password for the new account in both fields.
Picture
Your virtual face or picture.
One file only.
256 MB limit.
Allowed types: png gif jpg jpeg webp.
Contact settings
Personal contact form
Allow other users to contact you via a personal contact form which keeps your email address hidden. Note that some privileged users such as site administrators are still able to contact you even if you choose to disable this feature.
First Name
Last Name
App ID
Confirm Healthcare Professional
Consent UCB Communication
I have read & understood
Email Hash
First Name Hash
Last Name Hash
License Code
Post Code
Reset Token
I consent to receive email notification for Branded Product Information
I consent to receive email for Corporate Information
I consent to receive notification for Medical and scientific updates
I consent to receive email for Webinars/CME Event Notifications
I consent to receive notification for Market Research
Orbit ID
Reset Timestamp
Date
Time
Leave blank to use the time of form submission.
Registration Access Group
HCP User
Patient: Neupro
Patient: Cimzia
Patient: Briviact
Patient: Keppra
Patient: Vimpat
Patient: Evenity
Patient: Bimekizumab
Patient: Zilucoplan
Patient: Rozimab
Patient: Fintepla
Neurology
Immunology
Base Url
Locale
Therapeutic Area
- None -
immunology
neurology
Country
Speciality
- None -
General Neurologist
Neuroimmunologists
Neuromuscular specialists
Other neurologists
Other HCPs (non-neurology)
Unmet Needs
- None -
More effective options for refractory patients
Faster-acting therapies
Safer long-term treatments
Reduced treatment burden (e.g., SC or less frequent dosing)
Better biomarkers/monitoring tools
Clearer treatment sequencing guidelines
RSS feed